CDK5-mediated phosphorylation and autophagy of RKIP regulate neuronal death in Parkinson's disease

Neurobiology of Aging

Volumn 35, Issue 12, 2014, Pages 2870-2880

  Wen, Zheng ^a,b   Shu, Yang ^a,b   Gao, Caiyun ^a,b   Wang, Xuemin ^c   Qi, Guangjian ^a,b   Zhang, Pei ^a,b   Li, Man ^a,b   Shi, Jing ^a,b   Tian, Bo ^a,b  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^c SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Chaperone mediated autophagy; Cyclin dependent kinase 5; Parkinson's disease; Protein phosphorylation; Raf kinase inhibitor protein

Indexed keywords

CYCLIN DEPENDENT KINASE 5; HEAT SHOCK COGNATE PROTEIN 70; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; RAF PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPHAGY; BRAIN TISSUE; CARBOXY TERMINAL SEQUENCE; DOWN REGULATION; EXPOSURE; HELA CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NERVE CELL NECROSIS; NONHUMAN; PARKINSON DISEASE; PATHOGENESIS; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; REGULATORY MECHANISM; ANIMAL; CELL CULTURE; DISEASE MODEL; GENETICS; METABOLISM; MOLECULARLY TARGETED THERAPY; NERVE CELL; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY; RAT; SIGNAL TRANSDUCTION;

ANIMALS; AUTOPHAGY; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE 5; DISEASE MODELS, ANIMAL; HUMANS; MAP KINASE SIGNALING SYSTEM; MOLECULAR TARGETED THERAPY; NEURONS; PARKINSON DISEASE; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; PHOSPHORYLATION; RATS;

EID: 84911427463     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2014.05.034     Document Type: Article

References (49)

1. Al-Mulla F., Bitar M.S., Al-Maghrebi M., Behbehani A.I., Al-Ali W., Rath O., Doyle B., Tan K.Y., Pitt A., Kolch W. Raf kinase inhibitor protein RKIP enhances signaling by glycogen synthase kinase-3beta. Cancer Res. 2011, 71:1334-1343.
2. Bauer P.O., Goswami A., Wong H.K., Okuno M., Kurosawa M., Yamada M., Miyazaki H., Matsumoto G., Kino Y., Nagai Y., Nukina N. Harnessing chaperone-mediated autophagy for the selective degradation of mutant huntingtin protein. Nat. Biotechnol. 2010, 28:256-263.
3. Beach S., Tang H., Park S., Dhillon A.S., Keller E.T., Kolch W., Yeung K.C. Snail is a repressor of RKIP transcription in metastatic prostate cancer cells. Oncogene 2008, 27:2243-2248.
4. Bejarano E., Cuervo A.M. Chaperone-mediated autophagy. Proc. Am. Thorac. Soc. 2010, 7:29-39.
5. Beshir A.B., Ren G., Magpusao A.N., Barone L.M., Yeung K.C., Fenteany G. Raf kinase inhibitor protein suppresses nuclear factor-kappaB-dependent cancer cell invasion through negative regulation of matrix metalloproteinase expression. Cancer Lett. 2010, 299:137-149.
6. Bonni A., Brunet A., West A.E., Datta S.R., Takasu M.A., Greenberg M.E. Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms. Science 1999, 286:1358-1362.
7. Cheung Z.H., Ip N.Y. Cdk5: a multifaceted kinase in neurodegenerative diseases. Trends Cell Biol. 2012, 22:169-175.
8. Corbit K.C., Trakul N., Eves E.M., Diaz B., Marshall M., Rosner M.R. Activation of Raf-1 signaling by protein kinase C through a mechanism involving Raf kinase inhibitory protein. J.Biol. Chem. 2003, 278:13061-13068.
9. Cruz J.C., Tseng H.C., Goldman J.A., Shih H., Tsai L.H. Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles. Neuron 2003, 40:471-483.
10. Cuervo A.M., Gomes A.V., Barnes J.A., Dice J.F. Selective degradation of annexins by chaperone-mediated autophagy. J.Biol. Chem. 2000, 275:33329-33335.
11. Cuervo A.M., Stefanis L., Fredenburg R., Lansbury P.T., Sulzer D. Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy. Science 2004, 305:1292-1295.
12. Cui W., Li W., Han R., Mak S., Zhang H., Hu S., Rong J., Han Y. PI3-K/Akt and ERK pathways activated by VEGF play opposite roles in MPP+-induced neuronal apoptosis. Neurochem. Int. 2011, 59:945-953.
13. Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Aquantitative atlas of mitotic phosphorylation. Proc. Natl. Acad. Sci. U.S.A 2008, 105:10762-10767.
14. Dhavan R., Tsai L.H. Adecade of CDK5. Nat. Rev. Mol. Cell Biol. 2001, 2:749-759.
15. Escara-Wilke J., Yeung K., Keller E.T. Raf kinase inhibitor protein (RKIP) in cancer. Cancer Metastasis Rev. 2012, 31:615-620.
16. Eves E.M., Rosner M.R. MAP kinase regulation of the mitotic spindle checkpoint. Methods Mol. Biol. 2010, 661:497-505.
17. Folch J., Junyent F., Verdaguer E., Auladell C., Pizarro J.G., Beas-Zarate C., Pallas M., Camins A. Role of cell cycle re-entry in neurons: a common apoptotic mechanism of neuronal cell death. Neurotox. Res. 2012, 22:195-207.
18. George A.J., Holsinger R.M., McLean C.A., Tan S.S., Scott H.S., Cardamone T., Cappai R., Masters C.L., Li Q.X. Decreased phosphatidylethanolamine binding protein expression correlates with Abeta accumulation in the Tg2576 mouse model of Alzheimer's disease. Neurobiol. Aging 2006, 27:614-623.
19. Gomez-Santos C., Ferrer I., Reiriz J., Vinals F., Barrachina M., Ambrosio S. MPP+ increases alpha-synuclein expression and ERK/MAP-kinase phosphorylation in human neuroblastoma SH-SY5Y cells. Brain Res. 2002, 935:32-39.
20. Granovsky A.E., Rosner M.R. Raf kinase inhibitory protein: a signal transduction modulator and metastasis suppressor. Cell Res. 2008, 18:452-457.
21. Guegan J.P., Fremin C., Baffet G. The MAPK MEK1/2-ERK1/2 pathway and its implication in hepatocyte cell cycle control. Int. J. Hepatol. 2012, 2012:328372.
22. Hellmann J., Rommelspacher H., Muhlbauer E., Wernicke C. Raf kinase inhibitor protein enhances neuronal differentiation in human SH-SY5Y cells. Dev. Neurosci. 2010, 32:33-46.
23. Herrup K., Neve R., Ackerman S.L., Copani A. Divide and die: cell cycle events as triggers of nerve cell death. J.Neurosci. 2004, 24:9232-9239.
24. Huang L., Dai T., Lin X., Zhao X., Chen X., Wang C., Li X., Shen H., Wang X. MicroRNA-224 targets RKIP to control cell invasion and expression of metastasis genes in human breast cancer cells. Biochem. Biophys. Res. Commun. 2012, 425:127-133.
25. Jessberger S., Gage F.H., Eisch A.J., Lagace D.C. Making a neuron: cdk5 in embryonic and adult neurogenesis. Trends Neurosci. 2009, 32:575-582.
26. Kaushik S., Cuervo A.M. Chaperone-mediated autophagy: a unique way to enter the lysosome world. Trends Cell Biol. 2012, 22:407-417.
27. Keller E.T. Role of raf kinase inhibitor protein in pathophysiology of prostate cancer. Immunopathol Dis Therap. 2011, 2:89-94.
28. Keller E.T., Fu Z., Brennan M. The role of Raf kinase inhibitor protein (RKIP) in health and disease. Biochem. Pharmacol. 2004, 68:1049-1053.
29. King K.L., Cidlowski J.A. Cell cycle and apoptosis: common pathways to life and death. J.Cell. Biochem. 1995, 58:175-180.
30. Lorenz K., Lohse M.J., Quitterer U. Protein kinase C switches the Raf kinase inhibitor from Raf-1 to GRK-2. Nature 2003, 426:574-579.
31. Ma J., Li F., Liu L., Cui D., Wu X., Jiang X., Jiang H. Raf kinase inhibitor protein inhibits cell proliferation but promotes cell migration in rat hepatic stellate cells. Liver Int. 2009, 29:567-574.
32. Majeski A.E., Dice J.F. Mechanisms of chaperone-mediated autophagy. Int. J. Biochem. Cell Biol. 2004, 36:2435-2444.
33. Maki M., Matsukawa N., Yuasa H., Otsuka Y., Yamamoto T., Akatsu H., Okamoto T., Ueda R., Ojika K. Decreased expression of hippocampal cholinergic neurostimulating peptide precursor protein mRNA in the hippocampus in Alzheimer disease. J.Neuropathol. Exp. Neurol. 2002, 61:176-185.
34. Meloche S., Pouyssegur J. The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition. Oncogene 2007, 26:3227-3239.
35. Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L., Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M. Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis. Sci. Signal. 2010, 3:ra3.
36. Patrick G.N., Zukerberg L., Nikolic M., de la Monte S., Dikkes P., Tsai L.H. Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature 1999, 402:615-622.
37. Poma P., Labbozzetta M., Vivona N., Porcasi R., D'Alessandro N., Notarbartolo M. Analysis of possible mechanisms accounting for raf-1 kinase inhibitor protein downregulation in hepatocellular carcinoma. OMICS 2012, 16:579-588.
38. Qu D., Rashidian J., Mount M.P., Aleyasin H., Parsanejad M., Lira A., Haque E., Zhang Y., Callaghan S., Daigle M., Rousseaux M.W., Slack R.S., Albert P.R., Vincent I., Woulfe J.M., Park D.S. Role of Cdk5-mediated phosphorylation of Prx2 in MPTP toxicity and Parkinson's disease. Neuron 2007, 55:37-52.
39. Smith P.D., Crocker S.J., Jackson-Lewis V., Jordan-Sciutto K.L., Hayley S., Mount M.P., O'Hare M.J., Callaghan S., Slack R.S., Przedborski S., Anisman H., Park D.S. Cyclin-dependent kinase 5 is a mediator of dopaminergic neuron loss in a mouse model of Parkinson's disease. Proc. Natl. Acad. Sci. U.S.A 2003, 100:13650-13655.
40. Theroux S., Pereira M., Casten K.S., Burwell R.D., Yeung K.C., Sedivy J.M., Klysik J. Raf kinase inhibitory protein knockout mice: expression in the brain and olfaction deficit. Brain Res. Bull. 2007, 71:559-567.
41. Tian B., Yang Q., Mao Z. Phosphorylation of ATM by Cdk5 mediates DNA damage signalling and regulates neuronal death. Nat. Cell Biol. 2009, 11:211-218.
42. Wang Y., Martinez-Vicente M., Kruger U., Kaushik S., Wong E., Mandelkow E.M., Cuervo A.M., Mandelkow E. Synergy and antagonism of macroautophagy and chaperone-mediated autophagy in a cell model of pathological tau aggregation. Autophagy 2010, 6:182-183.
43. Wisniewski J.R., Nagaraj N., Zougman A., Gnad F., Mann M. Brain phosphoproteome obtained by a FASP-based method reveals plasma membrane protein topology. J.Proteome Res. 2010, 9:3280-3289.
44. Wong A.S., Lee R.H., Cheung A.Y., Yeung P.K., Chung S.K., Cheung Z.H., Ip N.Y. Cdk5-mediated phosphorylation of endophilin B1 is required for induced autophagy in models of Parkinson's disease. Nat. Cell Biol. 2011, 13:568-579.
45. Xue Y., Liu Z., Cao J., Ma Q., Gao X., Wang Q., Jin C., Zhou Y., Wen L., Ren J. GPS 2.1: enhanced prediction of kinase-specific phosphorylation sites with an algorithm of motif length selection. Protein Eng. Des. Sel. 2011, 24:255-260.
46. Yang Q., Mao Z. Parkinson disease: a role for autophagy?. Neuroscientist 2010, 16:335-341.
47. Yang Q., She H., Gearing M., Colla E., Lee M., Shacka J.J., Mao Z. Regulation of neuronal survival factor MEF2D by chaperone-mediated autophagy. Science 2009, 323:124-127.
48. Yeung K., Seitz T., Li S., Janosch P., McFerran B., Kaiser C., Fee F., Katsanakis K.D., Rose D.W., Mischak H., Sedivy J.M., Kolch W. Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP. Nature 1999, 401:173-177.
49. Zhu J.H., Guo F., Shelburne J., Watkins S., Chu C.T. Localization of phosphorylated ERK/MAP kinases to mitochondria and autophagosomes in Lewy body diseases. Brain Pathol. 2003, 13:473-481.